The webcast audience, comprising of strong representation across clinical, regulatory and IT, responded to polling questions that helped throw light on the current reality facing companies seeking to undertake the mammoth task of cross departmental unification.
Beginning with the polling question on “What has been your biggest challenge in relation to Clinical and Regulatory technologies?”, the attendee polling results across the five possible responses clearly showed that the regulatory and clinical departments are grappling with a multi-faceted challenge. The results showed nearly equal strength except for one. Laborious Upgrades and Validation Cycles ranked highest with 25%, but the lack of a Single Source of Truth, Complexity of Desired Process Automation, and Data Quality Not Available in Real-Time all tied at 21%. Trailing last at 13% was Lack of Common Terminology.
Integration Is Not the Same as Unification
After discussing the challenges, Vitthal delved into how today’s current architecture that is Web-based and involving loosely coupled integrations continues to present costly and complex issues that, at the end of the day, doesn’t represent what an effective drug development environment requires.
Presenting a clear end-to-end development process diagram and discussing the interwoven business processes of clinical and regulatory, Vitthal and Pratyusha shared how there is clearly a lot of back-and-forth between the two departments in terms of processes, data and documents, all of which requires a unified database. The need for a cognitive computing platform, a defined and shared library, repositories, inter-connected business processes and stakeholders is where unification can begin.
But where do most companies stand now in achieving a unified clinical and regulatory data management strategy? The webcast’s final polling question showed some interesting findings:
Intriguing questions from attendees on aspects like cross-department unification examples, disadvantages of unification, common data model responsibility, and recommended first steps were covered. We are confident that the information shared will likely lead to ongoing discussions within attending organizations. We encourage you to view the on-demand webcast for more details on what was shared. Have any questions? Send an email to email@example.com.